Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish population

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 10427-10433

  Ayada, C ^a   Toru, Ü ^a   Genc O ^a   Yerlikaya, A ^a   Sahin S ^a   Turgut, S ^b   Turgut, G ^b  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme; Chronic obstructive pulmonary disease; Renin angiotensin system; Turkish population

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA; ACE PROTEIN, HUMAN;

ACE GENE; ALLELE; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA ISOLATION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDEL MUTATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RISK FACTOR; TURK (PEOPLE); TURKEY (REPUBLIC); GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TURKEY;

GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; PEPTIDYL-DIPEPTIDASE A; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; TURKEY;

EID: 84917706717     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.December.12.4     Document Type: Article

References (21)

1. Busquets X, MacFarlane NG, Heine-Suñer D, Morlá M, et al. (2007). Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2: 329-334.
2. Forth R and Montgomery H (2003). ACE in COPD: a therapeutic target? Thorax 58: 556-558.
3. Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Updated guideline 2014) http://www.goldcopd.org/uploads/users/files?GOLD_Report2014_Feb07.pdf
4. Hollá L, Văsků A, Znojil V, Sisková L, et al. (1999). Association of 3 gene polymorphisms with atopic disease. J. Allergy Clin. Immunol. 103: 702-708.
5. Holmer SR and Schunkert H (1996). Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure. Basic Res. Cardiol. 91: 65-71.
6. Hopkinson NS, Nickol AH, Payne J, Hawe E, et al. (2004). Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170: 395-399.
7. Kanazawa H, Okamoto T, Hirata K and Yoshikawa J (2000). Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162: 1235-1238.
8. Kanazawa H, Otsuka T, Hirata K and Yoshikawa J (2002). Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 121: 697-701.
9. Kennon B, Petrie JR, Small, M and Connell JM (1999). Angiotensin-converting enzyme gene and diabetes mellitus. Diabet. Med. 16: 448-458.
10. Lee J, Nordestgaard BG and Dahl M (2009). Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity. Respir. Med. 103: 1286-1292.
11. Li W, Lan F, Yan F and Shen H (2013). Angiotensin-converting enzyme I/D polymorphism is associated with COPD risk in Asian population: evidence from a meta-analysis. COPD 10: 35-39.
12. Marin L, Colombo P, Bebawy M and Young PM (2011). Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management. Expert. Opin. Drug. Deliv. 8: 1205-1220.
13. Nakawah MO, Hawkins C and Barbandi F (2013). Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J. Am. Board Fam. Med. 26: 470-477.
14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, et al. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86: 1343-1346.
15. Rodriguez S, Gaunt TR and Day IN (2009). Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am. J. Epidemiol. 169: 505-514.
16. Sabbagh AS, Otrock ZK, Mahfoud ZR, Zaatari GS, et al. (2007). Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature. Mol. Biol. Rep. 34: 47-52.
17. Schuster H, Wienker TF, Stremmler U, Noll B, et al. (1995). An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am. J. Cardiol. 76: 601-603.
18. Shaw JG, Dent AG, Passmore LH, Burstow DJ, et al. (2012). Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD). BMC Pulm. Med. 12: 25.
19. Simsek S, Tekes S, Oral D, Turkyilmaz A, et al. (2013). The insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary disease. Genet. Mol. Res. 12: 1392-1398.
20. Turgut G, Turgut S, Genc O, Atalay A, et al. (2004). The angiotensin converting enzyme I/D polymorphism in Turkish athletes and sedentary controls. Acta Medica (Hradec Kralove) 47: 133-136.
21. Zhang X, Wang C, Dai H, Lin Y, et al. (2008). Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 13: 683-688.